Literature DB >> 17549500

[Intracellular signaling pathways of synovial fibroblasts in rheumatoid arthritis].

A Korb1, M Peters, I Meinecke, T Pap.   

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disease of still unknown etiology that results in characteristic destructive changes of the joints. Research of the past years has demonstrated that synovial fibroblasts play a central role in the initiation and perpetuation of these destructive changes. Stimulation of the synovial fibroblasts through complex and interacting intracellular signaling pathways results in a stable activation that is maintain even without continuous stimulation by inflammatory cells and their mediators. The pathological attachment to articular cartilage, increased secretion of matrix degrading enzymes and alterations in programmed cell death are main characteristics of synovial fibroblasts from patients with RA and result in the progressive destruction of articular structures. The permanent activation of a number of intracellular signaling pathways constitutes the underlying responsible mechanism for the activation of synovial fibroblasts in RA. These signaling pathways do not only show a high degree of complexity, but are also interconnected in multiple ways. This article summarizes recent findings on the activation of intracellular signaling pathways in fibroblasts and points to potential targets for novel therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17549500     DOI: 10.1007/s00393-007-0181-5

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  37 in total

1.  c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis.

Authors:  Z Han; D L Boyle; L Chang; B Bennett; M Karin; L Yang; A M Manning; G S Firestein
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

2.  Regulation of collagenase gene expression in synovial fibroblasts.

Authors:  C E Brinckerhoff; D T Auble
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

Review 3.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

4.  Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis.

Authors:  T Shouda; T Yoshida; T Hanada; T Wakioka; M Oishi; K Miyoshi; S Komiya; K Kosai; Y Hanakawa; K Hashimoto; K Nagata; A Yoshimura
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

Review 5.  Apoptosis in rheumatoid arthritis.

Authors:  Anja Baier; Ingmar Meineckel; Steffen Gay; Thomas Pap
Journal:  Curr Opin Rheumatol       Date:  2003-05       Impact factor: 5.006

6.  FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis.

Authors:  Jörg Schedel; Renate E Gay; Peter Kuenzler; Christian Seemayer; Beat Simmen; Beat A Michel; Steffen Gay
Journal:  Arthritis Rheum       Date:  2002-06

7.  Suppression of arthritic bone destruction by adenovirus-mediated dominant-negative Ras gene transfer to synoviocytes and osteoclasts.

Authors:  Aiichiro Yamamoto; Akira Fukuda; Hiroaki Seto; Tsuyoshi Miyazaki; Yuho Kadono; Yasuhiro Sawada; Ichiro Nakamura; Hideki Katagiri; Tomoichiro Asano; Yoshiya Tanaka; Hiromi Oda; Kozo Nakamura; Sakae Tanaka
Journal:  Arthritis Rheum       Date:  2003-09

8.  Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

Authors:  J Keffer; L Probert; H Cazlaris; S Georgopoulos; E Kaslaris; D Kioussis; G Kollias
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

Review 9.  The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models.

Authors:  Erik Lubberts; Marije I Koenders; Wim B van den Berg
Journal:  Arthritis Res Ther       Date:  2004-11-30       Impact factor: 5.156

10.  Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.

Authors:  J M Dayer; B Beutler; A Cerami
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.